Table 1—

Baseline characteristics of the PROactive study population and other clinical history (dependent on medical opinion of investigator)

n5,238
Demographic data
 Age (years)61.8 ± 7.7
 Male3,463 (66.1)
 Caucasian5,162 (98.5)
 Duration of type 2 diabetes (years)9.5 ± 7.0
Physical examination measurements
 Weight (kg)88.0 ± 15.6
 BMI (kg/m2)30.9 ± 4.8
 Waist circumference (cm)105.3 ± 11.9
 Systolic blood pressure (mmHg)143.4 ± 17.8
 Diastolic blood pressure (mmHg)83.0 ± 9.7
Laboratory data
 Triglycerides (mmol/l)2.24 ± 1.81
 HDL cholesterol (mmol/l)1.16 ± 0.31
 LDL cholesterol (mmol/l)2.96 ± 0.95
 Creatinine (μmol/l)82.55 ± 23.2
 HbA1c (%)8.08 ± 1.41
Other clinical history
 Angina3,010 (57.5)
 Claudication1,239 (23.7)
 Amputation72 (1.4)
 Transient ischemic attack299 (5.7)
 Retinopathy1,214 (23.2)
 Photocoagulation therapy*345 (28.4)
 Nephropathy41 (14.2)
 Neuropathy1,340 (25.6)
 Hypertension3,952 (75.4)
 Current/past smoking722 (13.8)/2,358 (45.0)
  • Data are means ± SD and n (%).

  • *

    * Expressed as a percentage of patients with retinopathy.